Explore how to mitigate the effects of cancer on the heart.

Science News

Heart Disease and Stroke Statistics - 2023 Update
State of the Science: The Relevance of Symptoms in Cardiovascular Disease and Research
Cardio-Oncology Drug Interactions
Dr. Jeremiah Stamler, 'the father of preventive cardiology,' dies at 102
Future Perspectives of Cardiovascular Biomarker Utilization in Cancer Survivors


PDE10A Inactivation Prevents Doxorubicin-Induced Cardiotoxicity and Tumor Growth
Diagnostic Value of the International Society of Cardio‐Oncology Definition for Suspected Immune Checkpoint Inhibitor–Associated Myocarditis
Mortality and Major Adverse Cardiac Events in Patients With Breast Cancer Receiving Radiotherapy: The First Decade
Complete Resolution of Technetium Pyrophosphate Uptake After Treatment of Transthyretin Cardiac Amyloidosis
Pulling Out All the Stops: A Case of Progressive Dyspnea
Audience members listen to a presentation during Scientific Sessions 2022 in Chicago, Illinois. Mark your calendar

Mark your calendars now to experience the premier global event focusing on improving health by championing scientific discovery and practice-changing educational content. We can't wait to see you November 2023!

The CLCD Council supports AHA objectives in clinical cardiology, promotes excellent clinical care, and fosters professional development and education for clinical cardiologists. Through council-sponsored symposia, panels, and scientific conferences, members can access and interpret new developments in the field and promote clinical cardiology to professional and lay audiences.

The GPM Council seeks to advance discovery and translation of biological insights from genetics and omics technologies to improve cardiovascular and brain health through better risk prediction, treatment and prevention for patients. Our expertise spans genetics, genomics, genomic medicine, epigenetics, transcriptomics, metabolomics, proteomics, microbiome, bioinformatics, computational science, and population health.

CEO Nancy Brown on Cardio Oncology

CEO Nancy Brown explains why the AHA is funding a Strategically Focused Research Network on cardio-oncology with $15 million and, working with CancerLinQ LLC, making oncology datasets available on a version of the Precision Medicine Platform.

American Heart Association Professional Members

Enjoy instant benefits!

  • Free Online Access to AHA Scientific Journals
  • Affiliate with our 16 Scientific Councils
  • Discounts on Scientific Conference Registration and Online Courses

Learn more about Professional Membership